The Female Health Company Schedules Fiscal Year End Conference Call for Monday, November 26, 2007

CHICAGO, Nov. 19  /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) today announced that it will host an investor conference call to discuss its operating results for the quarter and fiscal year ended September 30, 2007.  The Company plans to report its quarterly and year-end operating results on the morning of Monday, November 26, 2007, and an investor conference call has been scheduled for 11:00 a.m. Eastern Time (EST) on the same day.

Shareholders and other interested parties may participate in the conference call by dialing 888-603-6873 (international participants dial 973-582-2706) and referencing the conference ID 9473190, a few minutes before 11:00 a.m. EST on November 26, 2007.  A replay of the call will be available through December 10, 2007 by dialing 877-519-4471 (international callers dial 973-341-3080), and entering the conference ID 9473190.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC Female Condom(R), which is primarily distributed by public health organizations and donor groups in over 90 developing countries around the world. World-wide, the Female Condom is available in various programs in 108 countries. The Company owns certain worldwide rights to the FC Female Condom(R), including patents that have been issued in the United States, United Kingdom, Japan, France, Italy, Germany, Spain, the European Patent Convention, the People's Republic of China, Canada, South Korea and Australia. FC Female Condom(R) is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy.

"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:  The statements in this release which are not historical in fact are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government actions; currency risks; capacity; efficiency and supply constraints; and other risk detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events upon the Company's operations may vary from those currently anticipated.

For more information about the Female Health Company visit the Company's web site at http://www.femalehealth.com/ and http://www.femalecondom.org/.

To be added to the Company's e-mail alert list, please send an e-mail to  

DATASOURCE: The Female Health Company



CONTACT:  William R. Gargiulo, Jr., [phone], or Donna Felch, CFO,

[phone], both of The Female Health Company



Web site:  http://www.femalehealth.com/

http://www.femalecondom.org/ 

Copyright